RecruitingNot ApplicableNCT06158607

Pre-exposure Prophylaxis (PrEP) Adherence Intervention for Women with Substance Use Disorders

Development and Pilot Testing of an Addiction Clinic-Based PrEP Adherence Intervention for Women with Substance Use Disorders

Sponsor

The University of Texas Health Science Center, Houston

Enrollment

60 participants

Start Date

Jun 7, 2022

Study Type

INTERVENTIONAL

Conditions

Substance Use

Summary

The goal of this clinical trial is to test an addiction-clinic based behavioral intervention for increasing PrEP uptake and adherence among women who engage in high-risk sexual behaviors and problematic substance use. The main question it aims to answer is: • If the integrated intervention increase PrEP uptake and adherence compared to standard treatment Participants will * receive provision of PrEP information through 4 counseling sessions * prevention navigation * receive nurse practitioner prescribed PrEP in an addiction treatment setting Researchers will compare intervention group with standard treatment to see if the integrated intervention help increase PrEP uptake and adherence

Eligibility

Sex: FEMALEMin Age: 18 YearsMax Age: 60 Years

Plain Language Summary

Simplified for easier understanding

This study is testing a program to help Black/African American and Hispanic/Latina cisgender women with substance use disorders stay adherent to PrEP — a daily HIV prevention medication. The goal is to reduce HIV risk in a population that is both highly affected by HIV and faces barriers to consistent medication use. **You may be eligible if...** - You identify as a Black/African American or Hispanic/Latina cisgender woman - You have been diagnosed with a substance use disorder - You are HIV-negative - You have been sexually active with a male partner in the past 6 months - You are not currently using PrEP consistently **You may NOT be eligible if...** - You are HIV-positive - You do not have a substance use disorder - You are already adherent to PrEP - You do not meet the demographic or behavioral eligibility criteria Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

BEHAVIORALAddiction Clinic-Based PrEP Adherence Intervention for Women with Substance Use Disorders

Provision of PrEP information through 4 counseling sessions, prevention navigation, and nurse practitioner prescribed PrEP in an addiction treatment setting.

OTHERStandard of care treatment

Participants in substance use treatment will be given information and referral to a community partner who will evaluate them to determine if they could benefit from PrEP for HIV prevention

Locations(1)

Louis A. Faillace, MD, Department of Psychiatry and Behavioral Sciences, University of Texas Health Science Center at Houston

Houston, Texas, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06158607

Related Trials

Health Surveillance at Constructor University Bremen (CUB) and Among HAW-Hamburg Employees

NCT068993082 locations

Neurobehavioral Signatures of Sign- and Goal-Tracking in Emerging Adults: Translation of a Preclinical Model

NCT070940612 locations